Update in Tuberculosis 2009DALEY, Charles L.American journal of respiratory and critical care medicine. 2010, Vol 181, Num 6, pp 550-555, issn 1073-449X, 6 p.Article

Lung Disease Due to Nontuberculous Mycobacterial InfectionsCATANZARO, Antonino; DALEY, Charles L.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, 178 p.Serial Issue

Epidemiology of human pulmonary infection with nontuberculous mycobacteriaMARRAS, Theodore K; DALEY, Charles L.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, v, 553-567 [15 p.]Article

Pulmonary disease caused by rapidly growing mycobacteriaDALEY, Charles L; GRIFFITH, David E.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vii, 623-632 [10 p.]Article

Nontuberculous mycobacteria in the environmentFALKINHAM, Joseph O.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, v, 529-551 [23 p.]Article

Radiology of pulmonary Mycobacterium avium-intracellulare complexLEVIN, David L.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vi, 603-612 [10 p.]Article

Early therapy for latent tuberculosis infectionZIV, Elad; DALEY, Charles L; BLOWER, Sally M et al.American journal of epidemiology. 2001, Vol 153, Num 4, pp 381-385, issn 0002-9262Article

A systematic review of the clinical significance of pulmonary Mycobacterium kansasii isolates in HIV infectionMARRAS, Theodore K; DALEY, Charles L.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 4, pp 883-889, issn 1525-4135, 7 p.Article

Diagnosis, differentiating colonization, infection, and diseaseCATANZARO, Antonino.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vi, 599-601 [3 p.]Article

Management of disease due to Mycobacterium kansasiiGRIFFITH, David E.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vi, 613-621 [9 p.]Article

Medical management of pulmonary disease caused by Mycobacterium avium complexISEMAN, Michael D.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vii, 633-641 [9 p.]Article

Mycobacterium avium complex pulmonary disease in patients with pre-existing lung diseaseAKSAMIT, Timothy R.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vii, 643-653 [11 p.]Article

Nontuberculous mycobacteria in the HIV infected patientJONES, Denis; HAVLIR, Diane V.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, vii, 665-674 [10 p.]Article

Pathogenesis of nontuberculous mycobacteria infectionsMCGARVEY, Jeffery; BERMUDEZ, Luiz E.Clinics in chest medicine. 2002, Vol 23, Num 3, issn 0272-5231, v, 569-583 [15 p.]Article

Prospective Comparison of the Tuberculin Skin Test and 2 Whole-Blood Interferon-γ Release Assays in Persons with Suspected TuberculosisMAZUREK, Gerald H; WEIS, Stephen E; MOONAN, Patrick K et al.Clinical infectious diseases. 2007, Vol 45, Num 7, pp 837-845, issn 1058-4838, 9 p.Article

Tuberculosis in healthcare workers : A molecular epidemiologic study in San FranciscoONG, Adrian; RUDOY, Irina; GONZALEZ, Leah C et al.Infection control and hospital epidemiology. 2006, Vol 27, Num 5, pp 453-458, issn 0899-823X, 6 p.Article

Tuberculosis treatment outcomes: Directly observed therapy compared with self-administered therapyJASMER, Robert M; SEAMAN, Christopher B; GONZALEZ, Leah C et al.American journal of respiratory and critical care medicine. 2004, Vol 170, Num 5, pp 561-566, issn 1073-449X, 6 p.Article

Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex diseaseVAN INGEN, Jakko; TOTTEN, Sarah E; HEIFETS, Leonid B et al.International journal of antimicrobial agents (Print). 2012, Vol 39, Num 2, pp 173-176, issn 0924-8579, 4 p.Article

In Vitro Synergy between Clofazimine and Amikacin in Treatment of Nontuberculous Mycobacterial DiseaseVAN INGEN, Jakko; TOTTEN, Sarah E; HELSTROM, Niels K et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 12, pp 6324-6327, issn 0066-4804, 4 p.Article

Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosisBURMAN, William J; GOLDBERG, Stefan; VERNON, Andrew et al.American journal of respiratory and critical care medicine. 2006, Vol 174, Num 3, pp 331-338, issn 1073-449X, 8 p.Article

Treatment of multidrug-resistant tuberculosis in San Francisco : An outpatient-based approachBURGOS, Marcos; GONZALEZ, Leah C; PAZ, E. Antonio et al.Clinical infectious diseases. 2005, Vol 40, Num 7, pp 968-975, issn 1058-4838, 8 p.Article

Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis : An outcome and cost-effectiveness analysisJASMER, Robert M; SNYDER, David C; CHIN, Daniel P et al.American journal of respiratory and critical care medicine. 2000, Vol 162, Num 5, pp 1648-1652, issn 1073-449XArticle

Macrolide Treatment for Mycobacterium abscessus and Mycobacterium massiliense Infection and Inducible ResistanceCHOI, Go-Eun; SUNG JAE SHIN; JEONG, Byeong-Ho et al.American journal of respiratory and critical care medicine. 2012, Vol 186, Num 9, pp 917-925, issn 1073-449X, 9 p.Article

Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: A cost-effectiveness analysis based on a multicenter clinical trialJASMER, Robert M; SNYDER, David C; SAUKKONEN, Jussi J et al.Clinical infectious diseases. 2004, Vol 38, Num 3, pp 363-369, issn 1058-4838, 7 p.Article

Yield of sputum induction in the diagnosis of pleural tuberculosisCONDE, Marcus B; CHINDAMO LOIVOS, Angela; REZENDE, Valeria M et al.American journal of respiratory and critical care medicine. 2003, Vol 167, Num 5, pp 723-725, issn 1073-449X, 3 p.Article